BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25370301)

  • 1. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.
    Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H
    Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
    Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
    Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma.
    McCluggage WG; McBride HA
    Int J Gynecol Pathol; 2012 May; 31(3):206-10. PubMed ID: 22498936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms.
    Ronnett BM; Yemelyanova AV; Vang R; Gilks CB; Miller D; Gravitt PE; Kurman RJ
    Am J Surg Pathol; 2008 Dec; 32(12):1835-53. PubMed ID: 18813124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV infection and p16
    Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
    Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of CDK inhibitors and p53 in HPV-negative endocervical adenocarcinoma.
    Omori M; Hashi A; Kondo T; Katoh R; Hirata S
    Int J Gynecol Pathol; 2015 Mar; 34(2):196-203. PubMed ID: 25675191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix.
    Wang HL; Lu DW
    Am J Surg Pathol; 2004 Jul; 28(7):901-8. PubMed ID: 15223960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.